Provided by Tiger Trade Technology Pte. Ltd.

PolyPid Ltd.

5.19
-0.1800-3.35%
Post-market: 5.13-0.0600-1.16%19:30 EDT
Volume:168.31K
Turnover:885.85K
Market Cap:105.42M
PE:-3.52
High:5.55
Open:5.49
Low:5.06
Close:5.37
52wk High:5.73
52wk Low:3.06
Shares:20.31M
Float Shares:12.51M
Volume Ratio:2.38
T/O Rate:1.35%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4762
EPS(LYR):-2.0900
ROE:-243.59%
ROA:-74.63%
PB:19.57
PE(LYR):-2.48

Loading ...

PolyPid to Participate in the Craig-Hallum 23rd Annual Institutional Investor Conference

GlobeNewswire
·
May 20

PolyPid’s Earnings Call Signals Tightrope to Approval

TIPRANKS
·
May 20

PolyPid reports Q1 EPS (35c), consensus (43c)

TIPRANKS
·
May 14

PolyPid Ltd reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 13

PolyPid Advances D-PLEX₁₀₀ Toward FDA Review as Q1 2026 Loss Narrows and Debt Is Retired

TIPRANKS
·
May 13

PolyPid Q1 FY26 net loss narrows 7.61% to $7.7 million

Reuters
·
May 13

PolyPid Q1 EPS $(0.35) Beats $(0.43) Estimate

Benzinga Earnings
·
May 13

PolyPid Ltd - U.S. Commercial Partnership Discussions for D-Plex100 in Late Stages

THOMSON REUTERS
·
May 13

Press Release: PolyPid Provides Corporate Update and Reports First Quarter 2026 Financial Results

Dow Jones
·
May 13

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 13

PolyPid Ltd expected to post a loss of 43 cents a share - Earnings Preview

Reuters
·
May 11

PolyPid to Report First Quarter 2026 Financial Results and Operational Highlights on May 13, 2026

GlobeNewswire
·
May 06

PolyPid to Present Data from SHIELD II Phase 3 Trial Demonstrating Reduced Severity of Surgical Site Infection at Surgical Infection Society 2026 Annual Meeting

GlobeNewswire
·
Apr 28

Roth MKM Remains a Buy on PolyPid (PYPD)

TIPRANKS
·
Apr 15

PolyPid says SHIELD II data show D-PLEX100 doxycycline release lasts up to 32 days

Reuters
·
Apr 13

PolyPid starts trading on Frankfurt Stock Exchange under 2PV, adding to Nasdaq listing

Reuters
·
Apr 08

PolyPid director Yitzhak Jacobovitz files initial beneficial ownership statement

Reuters
·
Apr 07

PolyPid files Form 3 disclosing director Robert Benjamin Stein holdings

Reuters
·
Apr 06